top of page
Our Blog


Community Outreach Event – Festival of Flowers
Precision Clinical Research would like to thank everyone that joined us for our first 55 and over event at Colony West, Festival of Flowers. We had a wonderful turnout. Everyone danced and socialized as well as enjoyed a nice meal together. We were ever so grateful to be part of this, considering how little social interaction people have received in times of the COVID-19 pandemic. We ensured everyone who participated was fully vaccinated and kept a minimum of 6-8 people per t
hostrumon5
Aug 41 min read


About ORCA-3: A Clinical Study of Cytisinicline as a New Treatment Option to Help Adults Quit Smoking
Precision Clinical Research is participating in ORCA-3, a multicenter, double-blind, randomized, placebo-controlled phase 3 trial evaluating the efficacy and safety of cytisinicline in adult smokers. ORCA-3 is being conducted to assess the effectiveness and safety of cytisinicline as a smoking cessation therapy in adults who smoke cigarettes. Cytisinicline is a naturally occurring, plant-based investigational treatment that is believed to aid in smoking cessation by reducing
hostrumon5
Aug 43 min read
Sign up for text message alerts and get notified when new clinical trials are announced!
Text RESEARCH to
954-915-9991

bottom of page
